XML 103 R90.htm IDEA: XBRL DOCUMENT v3.22.4
Parent Only Condensed Financial Statements - Condensed Statements of Cash Flows (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:      
Net income $ 26,645 $ 28,401 $ 20,347
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Stock-based compensation 497 405 470
Benefit for deferred income taxes 224 1,465 (1,051)
Net cash provided by operating activities 24,194 42,855 16,990
Cash flows used in investing activities:      
Proceeds from issuance of subordinated debt 0 34,299 0
Cash flows from financing activities:      
Cash dividend payments on common stock (5,638) (5,757) (5,530)
Purchase and retirement of common stock 6,814 13,619 11,052
Proceeds from exercise of stock options 489 257 279
Net cash (used in) provided by financing activities 41,105 415,471 373,321
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR 163,467    
CASH AND CASH EQUIVALENTS AT END OF YEAR 31,170 163,467  
Non-cash investing and financing activities:      
Proceeds from stock issued under employee stock purchase plan 216 204 199
Parent Company      
Cash flows from operating activities:      
Net income 26,645 28,401 20,347
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Undistributed net income of subsidiary, net of distributions (66,583) (21,496) (5,328)
Stock-based compensation 497 405 470
Amortization of Debt Issuance Costs 145 0 0
Net (increase) decrease in other assets (499) 1 (208)
Net increase (decrease) in other liabilities 669 464 (31)
Benefit for deferred income taxes 15 6 75
Net cash provided by operating activities (39,111) 7,781 15,325
Cash flows used in investing activities:      
Investment in subsidiary 0 0 0
Proceeds from issuance of subordinated debt 30,000 34,299 0
Cash flows from financing activities:      
Cash dividend payments on common stock (5,638) (5,757) (5,530)
Purchase and retirement of common stock 6,814 13,619 11,052
Proceeds from exercise of stock options 489 256 279
Net cash (used in) provided by financing activities 18,253 15,383 (16,104)
Increase (decrease) in cash and cash equivalents (20,858) 23,164 (779)
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR 24,060 896 1,675
CASH AND CASH EQUIVALENTS AT END OF YEAR 3,202 24,060 896
Cash paid during the year for interest 1,431 119 153
Non-cash investing and financing activities:      
Proceeds from stock issued under employee stock purchase plan $ 216 $ 204 $ 199